Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Financial Results

Set Alert for Financial Results

Latest From Financial Results

Zoetis, Merck and IDEXX stand out in mixed H1 for industry leaders

Halfway through 2018, three of the leading animal health players have made great strides in terms of top-line growth. Others have fallen foul of currency exchange issues. Animal Pharm editor Joseph Harvey looks out how the first six months panned out for the top 10.

Financial Results Operations

Avivagen Q3 boosted by OxC-beta sales in Philippines

Canadian firm Avivagen has seen its revenues increase by nearly 153% in the third quarter of 2018. 
Financial Results Operations

Currency exchange masks robust Bayer Q2, North American gains

Bayer Animal Health's second quarter of 2018 has shown a small recovery after losses at the beginning of the year.

Financial Results Bayer Animal Health

Dechra confirms annual double-digit growth, eyes novel molecules

Dechra Pharmaceuticals has sustained its rapid growth of recent years and reported a sales increase of around 13% for fiscal 2018.

Dechra Pharmaceuticals R&D

Patterson begins fiscal 2019 with stronger sales growth

US distributor Patterson Companies has reported a 6% increase in first-quarter revenues.

Patterson Companies Financial Results

International growth boosts Phibro Q4, end-of-year performance

US firm Phibro Animal Health has recorded a 9% increase in sales in the fourth quarter of its fiscal 2018, backed by international growth.

Phibro Animal Health Financial Results
See All